Corneliu E. Giurgea

From WikiMD.com Medical Encyclopedia

Romanian psychologist and chemist



Corneliu E. Giurgea (6 January 1923 – 30 December 1995) was a Romanian psychologist and chemist who is best known for his work in the field of neuroscience and for coining the term "nootropic". He is credited with the synthesis of piracetam, the first compound to be classified as a nootropic.

Early Life and Education[edit | edit source]

Corneliu Giurgea was born in Romania in 1923. He pursued his higher education in the field of psychology and chemistry, which laid the foundation for his future contributions to neuroscience. Giurgea's academic journey was marked by a keen interest in understanding the biochemical processes underlying cognitive functions.

Career[edit | edit source]

Giurgea's career was primarily focused on the study of the brain and cognitive enhancers. He worked extensively in the development of compounds that could enhance memory and learning. His most notable achievement was the synthesis of piracetam in 1964, a drug that he believed could enhance cognitive functions without the usual side effects associated with psychotropic drugs.

Structure of Piracetam

Development of Nootropics[edit | edit source]

Giurgea coined the term "nootropic" in 1972 to describe a new class of psychotropic drugs that enhance cognitive function. The term is derived from the Greek words "nous," meaning "mind," and "tropein," meaning "to bend or turn." According to Giurgea, nootropics should enhance learning and memory, protect the brain against physical or chemical injuries, and possess few side effects.

Piracetam[edit | edit source]

Piracetam was the first compound to be classified as a nootropic. It was developed by Giurgea while he was working at the Belgian pharmaceutical company UCB (Union Chimique Belge). Piracetam is believed to enhance cognitive functions by modulating neurotransmitter systems, particularly the acetylcholine system, and improving cerebral blood flow.

Legacy[edit | edit source]

Corneliu Giurgea's work laid the groundwork for the development of a new class of drugs aimed at enhancing cognitive function. His pioneering research in nootropics has influenced subsequent studies in the field of cognitive enhancement and neuroprotection. Today, nootropics are widely used and researched for their potential benefits in treating cognitive impairments and enhancing mental performance.

Related Pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD